Clinical trial
Home-based Transcranial Direct Current Stimulation in Fibromyalgia Patients. Phase II, Randomized, Double-blind, Single-center Clinical Trial
NCT02652988 is registered in ClinicalTrials.gov with Wolnei Caumo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Home-based Transcranial Direct Current Stimulation in Fibromyalgia Patients. Phase II, Randomized, Double-blind, Single-center Clinical Trial
- Lead sponsor
- Wolnei Caumo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- June 12, 2018
- Enrollment
- 20 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.